1,249 Shares in Corteva, Inc. (NYSE:CTVA) Purchased by Crewe Advisors LLC

Crewe Advisors LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,249 shares of the company’s stock, valued at approximately $72,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. American Century Companies Inc. lifted its holdings in Corteva by 12.5% in the third quarter. American Century Companies Inc. now owns 96,151 shares of the company’s stock valued at $4,919,000 after acquiring an additional 10,711 shares during the period. BKM Wealth Management LLC purchased a new stake in Corteva during the fourth quarter valued at approximately $27,000. SG Americas Securities LLC lifted its position in shares of Corteva by 206.0% during the 4th quarter. SG Americas Securities LLC now owns 31,875 shares of the company’s stock valued at $1,527,000 after buying an additional 21,457 shares in the last quarter. CoreCap Advisors LLC grew its stake in shares of Corteva by 41.2% during the 4th quarter. CoreCap Advisors LLC now owns 8,852 shares of the company’s stock valued at $424,000 after acquiring an additional 2,585 shares during the period. Finally, Salem Investment Counselors Inc. raised its stake in Corteva by 19.8% during the 4th quarter. Salem Investment Counselors Inc. now owns 2,321 shares of the company’s stock worth $111,000 after acquiring an additional 383 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 0.7 %

NYSE CTVA traded up $0.40 during trading on Friday, hitting $55.68. The stock had a trading volume of 485,688 shares, compared to its average volume of 3,412,561. Corteva, Inc. has a one year low of $43.22 and a one year high of $58.76. The stock has a 50 day simple moving average of $53.70 and a 200 day simple moving average of $53.52. The stock has a market capitalization of $38.81 billion, a price-to-earnings ratio of 69.99, a P/E/G ratio of 1.45 and a beta of 0.77. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.97 and a current ratio of 1.51.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.79 by $0.10. The firm had revenue of $4.49 billion during the quarter, compared to analyst estimates of $4.65 billion. Corteva had a return on equity of 6.68% and a net margin of 3.32%. Corteva’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same period last year, the company earned $1.16 EPS. Sell-side analysts predict that Corteva, Inc. will post 2.78 earnings per share for the current year.

Insider Transactions at Corteva

In related news, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $57.41, for a total value of $2,281,243.76. Following the completion of the sale, the senior vice president now owns 126,628 shares in the company, valued at $7,269,713.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of the stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the sale, the senior vice president now owns 126,628 shares of the company’s stock, valued at approximately $7,269,713.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Samuel R. Eathington sold 31,686 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the completion of the sale, the insider now owns 53,854 shares in the company, valued at $3,104,144.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 83,556 shares of company stock worth $4,795,016. Insiders own 0.14% of the company’s stock.

Wall Street Analyst Weigh In

CTVA has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $65.00 target price on shares of Corteva in a research note on Wednesday, June 12th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $57.00 price objective (down previously from $58.00) on shares of Corteva in a research note on Friday, April 12th. Royal Bank of Canada lifted their target price on Corteva from $62.00 to $64.00 and gave the company an “outperform” rating in a research note on Monday, May 6th. OTR Global restated a “negative” rating on shares of Corteva in a research note on Friday, June 7th. Finally, Mizuho reduced their price objective on shares of Corteva from $61.00 to $60.00 and set a “buy” rating on the stock in a research report on Tuesday, June 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus price target of $63.00.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.